Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.

IF 19.3 1区 医学 Q1 CRITICAL CARE MEDICINE
Anna J Podolanczuk, Gary M Hunninghake, Kevin C Wilson, Yet H Khor, Fayez Kheir, Brandon Pang, Ayodeji Adegunsoye, Gretchen Cararie, Tamera J Corte, Jim Flanagan, Gunnar Gudmundsson, Lida P Hariri, Hiroto Hatabu, Stephen M Humphries, Bhavika Kaul, John S Kim, Melanie Konigshoff, Jonathan A Kropski, Joyce S Lee, Fengming Luo, David A Lynch, Fernando J Martinez, Sydney B Montesi, Yuben Moodley, Justin M Oldham, Sara Piciucchi, Rachel K Putman, Luca Richeldi, Ivan O Rosas, Margaret L Salisbury, Mary M Salvatore, Moises Selman, Joon Beom Seo, Jin Woo Song, Carey C Thomson, Marina Vivero, Louise V Wain, Marlies Wijsenbeek, David A Schwartz, Christopher J Ryerson
{"title":"Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.","authors":"Anna J Podolanczuk, Gary M Hunninghake, Kevin C Wilson, Yet H Khor, Fayez Kheir, Brandon Pang, Ayodeji Adegunsoye, Gretchen Cararie, Tamera J Corte, Jim Flanagan, Gunnar Gudmundsson, Lida P Hariri, Hiroto Hatabu, Stephen M Humphries, Bhavika Kaul, John S Kim, Melanie Konigshoff, Jonathan A Kropski, Joyce S Lee, Fengming Luo, David A Lynch, Fernando J Martinez, Sydney B Montesi, Yuben Moodley, Justin M Oldham, Sara Piciucchi, Rachel K Putman, Luca Richeldi, Ivan O Rosas, Margaret L Salisbury, Mary M Salvatore, Moises Selman, Joon Beom Seo, Jin Woo Song, Carey C Thomson, Marina Vivero, Louise V Wain, Marlies Wijsenbeek, David A Schwartz, Christopher J Ryerson","doi":"10.1164/rccm.202505-1054ST","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> There is growing interest in identifying early stages of interstitial lung disease (ILD) to improve patient outcomes. This document reviews updated evidence on interstitial lung abnormalities (ILAs); provides suggestions for screening, evaluation, and management; proposes criteria for distinguishing ILAs from ILD; and identifies research priorities. <b>Methods:</b> A committee of clinical and methodology experts met by video conference to define ILAs and ILD by consensus and voted on 11 prespecified questions after reviewing synthesized evidence from a systematic literature search. Agreement of ≥70% was required to approve each suggestion. <b>Results:</b> ILA is defined as nondependent bilateral parenchymal abnormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion, traction bronchiectasis, and/or honeycombing involving ≥5% of a lung zone. The updated definition removes the prior exclusion of high-risk populations. ILD is distinguished from ILAs by symptoms (dyspnea/cough) attributable to an interstitial process, abnormal or declining lung function, fibrotic (honeycombing and/or reticulation with traction bronchiectasis involving ≥5% of total lung volume) or progressive imaging abnormalities, and/or specific fibrotic ILD patterns on imaging or pathology. Suggestions include ILA/ILD assessment on imaging acquired for lung cancer screening, screening adults with connective tissue disease and first-degree relatives of patients with familial pulmonary fibrosis, assessing baseline symptoms and pulmonary function among those with ILAs, and monitoring ILAs with chest computed tomography every 2-3 years. <b>Conclusions:</b> This document presents a comprehensive literature review of ILAs with updates to the Fleischner Society ILA definition, establishes a working ILD definition, and provides evidence-based suggestions for ILA evaluation and management.</p>","PeriodicalId":7664,"journal":{"name":"American journal of respiratory and critical care medicine","volume":" ","pages":"1132-1155"},"PeriodicalIF":19.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory and critical care medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1164/rccm.202505-1054ST","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is growing interest in identifying early stages of interstitial lung disease (ILD) to improve patient outcomes. This document reviews updated evidence on interstitial lung abnormalities (ILAs); provides suggestions for screening, evaluation, and management; proposes criteria for distinguishing ILAs from ILD; and identifies research priorities. Methods: A committee of clinical and methodology experts met by video conference to define ILAs and ILD by consensus and voted on 11 prespecified questions after reviewing synthesized evidence from a systematic literature search. Agreement of ≥70% was required to approve each suggestion. Results: ILA is defined as nondependent bilateral parenchymal abnormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion, traction bronchiectasis, and/or honeycombing involving ≥5% of a lung zone. The updated definition removes the prior exclusion of high-risk populations. ILD is distinguished from ILAs by symptoms (dyspnea/cough) attributable to an interstitial process, abnormal or declining lung function, fibrotic (honeycombing and/or reticulation with traction bronchiectasis involving ≥5% of total lung volume) or progressive imaging abnormalities, and/or specific fibrotic ILD patterns on imaging or pathology. Suggestions include ILA/ILD assessment on imaging acquired for lung cancer screening, screening adults with connective tissue disease and first-degree relatives of patients with familial pulmonary fibrosis, assessing baseline symptoms and pulmonary function among those with ILAs, and monitoring ILAs with chest computed tomography every 2-3 years. Conclusions: This document presents a comprehensive literature review of ILAs with updates to the Fleischner Society ILA definition, establishes a working ILD definition, and provides evidence-based suggestions for ILA evaluation and management.

肺间质性异常的评估与处理方法。美国胸科学会官方临床声明。
背景:鉴别早期间质性肺疾病(ILD)以改善患者预后的研究越来越受到关注。本文综述了间质性肺异常(ILA)的最新证据,为筛查、评估和管理提供了建议,提出了区分ILA和ILD的标准,并确定了研究重点。方法:一个由临床和方法学专家组成的委员会通过视频会议,通过共识来定义ILA和ILD,并在回顾系统文献检索的综合证据后,对11个预先指定的问题进行投票。每项建议都需要70%或以上的同意才能通过。结果:ILA被定义为非依赖性双侧实质CT异常,包括磨玻璃或网状,肺扭曲,牵引性支气管扩张和/或至少5%肺区蜂窝状。更新后的定义取消了对高危人群的预先排除。ILD与ILA的区别在于,其症状(呼吸困难/咳嗽)可归因于间质性进展、肺功能异常或下降、纤维化(蜂窝状和/或网状伴牵引性支气管扩张,至少占肺总容积的5%)或进行性影像学异常,和/或影像学或病理学上的特异性纤维化ILD模式。建议包括对肺癌筛查获得的影像学进行ILA/ILD评估,筛查成人结缔组织病和家族性肺纤维化患者的一级亲属,评估ILA患者的基线症状和肺功能,每2-3年用胸部CT监测ILA。结论:本文对ILA进行了全面的文献综述,更新了Fleischner协会的ILA定义,建立了一个有效的ILD定义,并为ILA的评估和管理提供了基于证据的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
27.30
自引率
4.50%
发文量
1313
审稿时长
3-6 weeks
期刊介绍: The American Journal of Respiratory and Critical Care Medicine focuses on human biology and disease, as well as animal studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients. Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish clinical trials and outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Critical Care Perspectives or Pulmonary Perspectives. These are generally focused on a more limited area and advance a concerted opinion about care for a specific process. Concise Clinical Reviews provide an evidence-based synthesis of the literature pertaining to topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. Images providing advances or unusual contributions to the field are published as Images in Pulmonary, Critical Care, Sleep Medicine and the Sciences. A recent trend and future direction of the Journal has been to include debates of a topical nature on issues of importance in pulmonary and critical care medicine and to the membership of the American Thoracic Society. Other recent changes have included encompassing works from the field of critical care medicine and the extension of the editorial governing of journal policy to colleagues outside of the United States of America. The focus and direction of the Journal is to establish an international forum for state-of-the-art respiratory and critical care medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信